The molecular basis of simple relationships between exposure concentration and toxic effects with time

Henk A Tennekes1, Francisco Sánchez-Bayo

  • 1Experimental Toxicology Services (ETS) Nederland BV, Frankensteeg 4, 7201 KN Zutphen, The Netherlands. info@toxicology.nl

Toxicology
|April 23, 2013
PubMed

Insights

The Druckrey-Küpfmüller model shows that chemical toxicity depends on receptor binding reversibility. Time-cumulative toxicants, like those with irreversible binding, pose risks underestimated by current environmental risk assessment methods.

Area of Science:

  • Environmental toxicology
  • Molecular toxicology
  • Biochemical mechanisms of toxicity

Background:

  • Current toxicological understanding relies on toxicodynamic and toxicokinetic models.
  • These models often do not fully capture the temporal dynamics of chemical toxicity.
  • The relationship between exposure concentration, time, and toxic effects requires a deeper mechanistic understanding.

Purpose of the Study:

  • To reintroduce and validate the Druckrey-Küpfmüller toxicity model for ecotoxicology.
  • To demonstrate the applicability of this model to a wide range of toxic compounds.
  • To highlight the implications of the model for environmental risk assessment.

Main Methods:

  • Review and reintroduction of the Druckrey-Küpfmüller toxicity model.
  • Analysis of chemical toxicity based on receptor binding reversibility (irreversible vs. reversible).
  • Evaluation of time-cumulative toxicity and its dependence on exposure concentration and time.

Main Results:

  • The Druckrey-Küpfmüller model, initially for carcinogens, is applicable to diverse ecotoxicological compounds.
  • Chemicals with irreversible or slowly reversible receptor binding exhibit time-cumulative toxicity.
  • Time-dependent toxicity is significantly influenced by the reversibility of critical receptor interactions.

Conclusions:

  • The mechanism of toxic action, particularly receptor binding reversibility, is crucial for risk assessment.
  • Traditional risk assessment protocols underestimate toxicants with time-cumulative toxicity.
  • New assessment procedures are necessary to accurately evaluate risks posed by time-dependent toxicants to ecosystems and human health.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect01:26

Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect

The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...